Clinical Trials Directory

Trials / Completed

CompletedNCT01549600

Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose

A Randomized, Controlled Study To Compare the Effects of 2 Types of Dietary Fiber, Psyllium and Microcrystalline Cellulose, on Glycemic Measures in Subjects With Pre-type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting glucose.

Detailed description

This study will be conducted at a single study center. Approximately 40 subjects with pre-type 2 diabetes will be enrolled and randomized in this study. This 22-week study consists of 3 periods: an 8-week treatment period (Visits 2-4), a 6-week washout period, and an 8-week treatment period (Visits 5-7).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTpsyllium1 level tablespoon (\~ 5.1 g psyllium husk in the psyllium product) mixed with at least 8 ounces of water, taken twice daily
DIETARY_SUPPLEMENTMicrocrystalline Cellulose1 level tablespoon (\~ 1.18 g MCC in the MCC product) mixed with at least 8 ounces of water, taken twice a day

Timeline

Start date
2012-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-03-09
Last updated
2014-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01549600. Inclusion in this directory is not an endorsement.